Patient s condition Patient s Condition - Sourced: Soliant Health For patients with mild symptoms and remaining pancreatic function, oral semaglutide may be effective in controlling blood sugar
In a statement released March 10, Novo Nordisk said it initially received inspectional observations from the FDA in February 2025, and that it has been working diligently to address those observations ever since. In the statement on Tuesday, the drugmaker acknowledged it received the warning letter and that it welcomes further dialogue with the US FDA. The company said it is working diligently to address the concerns of the FDA
Clinical Evidence: GLP-1 Treatment for NAFLD in the UK Emerging clinical evidence suggests GLP-1 receptor agonists may offer therapeutic benefits for patients with NAFLD and NASH, though it is important to note that these medications are not currently licensed specifically for liver disease treatment in the UK
Eating a nutrient-dense diet, exercising regularly, and prioritizing sleep are foundational habits that not only increase natural GLP-1 levels, but also provide dividends for overall longevity and well-being
Classes and events are happening right now at participating gyms, online through SilverSneakers LIVE, and at community centers near you
